Connection

TAO SHEN to Antineoplastic Agents

This is a "connection" page, showing publications TAO SHEN has written about Antineoplastic Agents.
Connection Strength

0.222
  1. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK. Biochem Pharmacol. 2016 09 15; 116:39-50.
    View in: PubMed
    Score: 0.070
  2. Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells. Carcinogenesis. 2014 Jan; 35(1):192-200.
    View in: PubMed
    Score: 0.057
  3. Sesquiterpenoids from myrrh inhibit androgen receptor expression and function in human prostate cancer cells. Acta Pharmacol Sin. 2011 Mar; 32(3):338-44.
    View in: PubMed
    Score: 0.048
  4. Targeting Oncogenic RET Kinase by Simultaneously Inhibiting Kinase Activity and Degrading the Protein. J Med Chem. 2025 01 09; 68(1):81-94.
    View in: PubMed
    Score: 0.031
  5. Ciclopirox induces autophagy through reactive oxygen species-mediated activation of JNK signaling pathway. Oncotarget. 2014 Oct 30; 5(20):10140-50.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.